Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Air Date: November 19, 2019 | Length: 28:22
Share this episode:
In this episode of Behind the Breakthrough, we hear from cardiac pathologist and award-winning principal investigator at the McEwen Stem Cell Institute Dr. Michael Laflamme. His mission: to restore the function of injured hearts by replacing scar tissue with healthy heart muscle cells made from stem cells. He shares why it's important to put your career aspirations to paper early on, what it's like to co-found a company that's been acquired for $1US billion, and why researchers should try to be scientifically fearless.
Dr. Laflamme alongside Dr. Gordon Keller, director of the McEwen Stem Cell Institute, was awarded the UHN 2017 Inventor of the Year award, for their pioneering contributions to the study of stem cells and the field of regenerative medicine.
Dr. Michael Laflamme is a practicing cardiac pathologist, holds the Robert R. McEwen Chair in Cardiac Regenerative Medicine at UHN, is a Principal Investigator at the McEwen Stem Cell Institute, and is a Senior Scientist at the Toronto General Hospital Research Institute. Dr. Laflamme's laboratory is focused on developing stem cell-based therapies to restore damaged hearts in heart failure patients.